MULTIVARIATE MODELS FOR PREDICTING PROGRESSION TO AIDS AND SURVIVAL IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS

被引:40
作者
BLATT, SP
MCCARTHY, WF
BUCKOKRASNICKA, B
MELCHER, GP
BOSWELL, RN
DOLAN, MJ
FREEMAN, TM
RUSNAK, JM
HENSLEY, RE
WARD, WW
BARNES, D
HENDRIX, CW
机构
[1] SW FDN BIOMED RES, CTR AIDS RES, WILFORD HALL MED CTR, DEPT INFECT DIS, SAN ANTONIO, TX 78284 USA
[2] SW FDN BIOMED RES, CTR AIDS RES, WILFORD HALL MED CTR, DEPT ALLERGY IMMUNOL, SAN ANTONIO, TX 78284 USA
[3] SW FDN BIOMED RES, CTR AIDS RES, WILFORD HALL MED CTR, DEPT CLIN IMMUNOL, SAN ANTONIO, TX 78284 USA
[4] MIL MED CONSORTIUM APPL RETROVIRAL RES, SAN ANTONIO, TX USA
[5] HENRY M JACKSON FDN ADV MIL MED, ROCKVILLE, MD USA
[6] UNIFORMED SERV UNIV HLTH SCI, SCH MED, DEPT SURG, BETHESDA, MD 20814 USA
关键词
D O I
10.1093/infdis/171.4.837
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nine hundred thirty persons enrolled in the US Air Force Human Immunodeficiency Virus (HIV) Natural History Study were evaluated with a standard battery of 30 potential surrogate markers of disease progression. A risk score for predicting progression to AIDS was then calculated for each patient in the cohort by using the four highest-ranking variables from multivariate analysis: percentage of CD4 CD29 cells, anergy status, age, and hemoglobin. For predicting survival, beta(2)-microglobulin replaced age in the Cox model. Stratification according to the risk score demonstrated that rates of progression to AIDS and survival were significantly different between risk groups (P < .0001). The novel combination of these markers results in extremely accurate risk scores, which may serve as the basis for the development of true surrogate markers of disease progression.
引用
收藏
页码:837 / 844
页数:8
相关论文
共 35 条
  • [21] SURROGATE MARKERS IN AIDS CLINICAL-TRIALS - CONCEPTUAL BASIS, VALIDATION, AND UNCERTAINTIES
    LAGAKOS, SW
    [J]. CLINICAL INFECTIOUS DISEASES, 1993, 16 : S22 - S25
  • [22] SURROGATE MARKERS IN AIDS - WHERE ARE WE - WHERE ARE WE GOING
    LAGAKOS, SW
    HOTH, DF
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 116 (07) : 599 - 601
  • [23] PREDICTING PROGRESSION TO AIDS - COMBINED USEFULNESS OF CD4 LYMPHOCYTE COUNTS AND P24 ANTIGENEMIA
    MACDONELL, KB
    CHMIEL, JS
    POGGENSEE, L
    WU, S
    PHAIR, JP
    [J]. AMERICAN JOURNAL OF MEDICINE, 1990, 89 (06) : 706 - 712
  • [24] TUBERCULIN AND ANERGY TESTING IN HIV-SEROPOSITIVE AND HIV-SERONEGATIVE PERSONS
    MARKOWITZ, N
    HANSEN, NI
    WILCOSKY, TC
    HOPEWELL, PC
    GLASSROTH, J
    KVALE, PA
    MANGURA, BT
    OSMOND, D
    WALLACE, JM
    ROSEN, MJ
    REICHMAN, LB
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (03) : 185 - 193
  • [25] SEROPOSITIVITY FOR HIV AND THE DEVELOPMENT OF AIDS OR AIDS RELATED CONDITION - 3-YEAR FOLLOW UP OF THE SAN-FRANCISCO-GENERAL-HOSPITAL COHORT
    MOSS, AR
    BACCHETTI, P
    OSMOND, D
    KRAMPF, W
    CHAISSON, RE
    STITES, D
    WILBER, J
    ALLAIN, JP
    CARLSON, J
    [J]. BRITISH MEDICAL JOURNAL, 1988, 296 (6624) : 745 - 750
  • [26] IMMUNE ACTIVATION MARKERS AND AIDS PROGNOSIS
    OSMOND, DH
    SHIBOSKI, S
    BACCHETTI, P
    WINGER, EE
    MOSS, AR
    [J]. AIDS, 1991, 5 (05) : 505 - 511
  • [27] STUDIES OF PROGNOSTIC MARKERS IN HIV-INFECTION - IMPLICATIONS FOR PATHOGENESIS
    PHILLIPS, AN
    [J]. AIDS, 1992, 6 (11) : 1391 - 1394
  • [28] PHILLIPS AN, 1991, J ACQ IMMUN DEF SYND, V4, P970
  • [29] ROTHSTEIN DM, 1991, J IMMUNOL, V146, P1175
  • [30] HUMAN NAIVE AND MEMORY T-CELLS - REINTERPRETATION OF HELPER-INDUCER AND SUPPRESSOR-INDUCER SUBSETS
    SANDERS, ME
    MAKGOBA, MW
    SHAW, S
    [J]. IMMUNOLOGY TODAY, 1988, 9 (7-8): : 195 - 199